INCY 15 (Jakafi 15 mg)
Generic Name: ruxolitinib
Pill imprint INCY 15 has been identified as Jakafi 15 mg.
Jakafi is used in the treatment of myelofibrosis; polycythemia vera; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 15 mg
- Elliptical / Oval
- Prescription only
sodium starch glycolate type A potato
More about Jakafi (ruxolitinib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.